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SUMMARY
Methylglyoxal is a highly reactive dicar-
bonyl degradation product formed from tri-
ose phosphates during glycolysis. Methyl-
glyoxal forms stable adducts primarily
with arginine residues of intracellular pro-
teins. Thebiologic roleof this covalentmod-
ification in regulating cell function is not
known. Here, we report that in retinal Mu¨ller
cells, increased glycolytic flux causes in-
creased methylglyoxal modification of the
corepressor mSin3A. Methylglyoxal modifi-
cation of mSin3A results in increased re-
cruitment of O-GlcNAc transferase to an
mSin3A-Sp3 complex, with consequent in-
creased modification of Sp3 by O-linked
N-acetylglucosamine. This modification of
Sp3 causes decreased binding of the re-
pressor complex to a glucose-responsive
GC box in the angiopoietin-2 promoter, re-
sulting in increased Ang-2 expression. A
similarmechanism involvingmethylglyoxal-
modification of other coregulator proteins
may play a role in the pathobiology of a vari-
ety of conditions associated with changes
in methylglyoxal concentration, including
cancer and diabetic vascular disease.
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AINTRODUCTIONMethylglyoxal (MG) is a highly reactive a-oxoaldehydeformed in cells primarily from the triose phosphate intermedi-ates of glycolysis, dihydroxyacetone phosphate and glyceral-
dehyde 3-phosphate (Phillips and Thornalley, 1993; Richard,
1993). It is the major physiologic substrate for the enzyme
glyoxalase I, which is encoded by the GLO1 gene. Together
with glyoxalase II and a catalytic amount of GSH, glyoxalase I
reduces methylglyoxal to D-lactate (Thornalley, 2003a). In
cells, methylglyoxal reacts almost exclusively with arginine
residues to form the major methylglyoxal-derived epitope hy-
droimidazolone MG-H1 (Na-acetyl-Nd (5-hydro-5-methyl)-
4-imidazolone; Ahmed and Thornalley, 2003). Changes in
methylglyoxal concentration have been implicated in the
pathobiology of a variety of important diseases, including
cancer, malaria, renal failure, and diabetic vascular disease
(Agalou et al., 2003; Beisswenger et al., 2003; Creighton
et al., 2003; Iozef et al., 2003; Sakamoto et al., 2001; Thor-
nalley, 2003a; Thornalley, 2003b).
Levels of hyperglycemia that cause diabetic vascular pa-
thology increase the concentration of both methylglyoxal
(Shinohara et al., 1998) and the methylglyoxal arginine-
derived hydroimidazolone adduct MG-H1 in aortic endothe-
lial cells (Du et al., 2003), and increased retinal levels of
MG-H1 in diabetic rats are associated with the formation
of acellular capillaries, the major structural lesion of both hu-
man nonproliferative retinopathy and experimental diabetic
retinopathy (Hammes et al., 2003). In diabetic retinal capillar-
ies, the earliest morphological changes are pericyte loss
and acellular capillary formation. The primary pathologic
processes of retinal pericyte loss and acellular capillaryCell 124, 275–286, January 27, 2006 ª2006 Elsevier Inc. 275
formation are regulated by complex context-dependent in-
teractions among a number of pro- and antiangiogenic fac-
tors (Carmeliet, 2003; Hanahan, 1997; Jain, 2003), including
angiopoietin-2 (Ang-2). When insufficient levels of VEGF and
other angiogenic signals are present, Ang-2 causes endo-
thelial cell death and vessel regression (Gale et al., 2002;
Hackett et al., 2002; Maisonpierre et al., 1997). Diabetes in-
duces a significant increase in retinal expression of Ang-2 in
rats (Hammes et al., 2004), and diabetic Ang-2+/ mice have
both decreased pericyte loss and reduced acellular capillary
formation (Hammes et al., 2002). The observed association
between diabetes-induced increased retinal levels of MG-
H1 and the formation of acellular capillaries led us to hypoth-
esize that methylglyoxal might directly regulate transcription
of genes involved in acellular capillary formation, such as
Ang-2, by covalently modifying proteins that bind to the
Ang-2 promoter.
In the present study, we demonstrate that in retinal Mu¨ller
cells, the major cell type expressing angiopoietin-2 in the
retina (Sarthy et al., 1998), increased glycolytic flux causes
increased methylglyoxal modification of the corepressor
mSin3A. Methylglyoxal modification of mSin3A results in
increased recruitment of O-GlcNAc transferase to an
mSin3A-Sp3 complex, with consequent increased modifica-
tion of Sp3 by O-linked N-acetylglucosamine. This modifica-
tion of Sp3 causes decreased binding of the repressor com-
plex to a glucose-responsive GC box in the angiopoietin-2
promoter, resulting in increased Ang-2 expression. This
novel mechanism for regulating gene expression may play
a role in the pathobiology of a variety of conditions associ-
ated with changes in methylglyoxal concentration, including
cancer, malaria, renal failure, and diabetic vascular disease.
RESULTS
Ang-2 Transcription Is Induced in High-Glucose
Conditions
We first examined the effect of glyoxalase I (GLO1) overex-
pression on high glucose-flux-induced expression of Ang-2
mRNA in retinal Mu¨ller cells (rMC-1). Since incubation in
high glucose increases intracellular glucose flux and methyl-
glyoxal concentration in cells damaged by hyperglycemia
(Brownlee, 2001), we first examined the effects of incubating
Mu¨ller cells in 30 mM glucose. Under these conditions, gly-
colytic flux increased 2-fold (data not shown), and intracellu-
lar methylglyoxal concentration increased 1.7-fold (2.6 ± 0.1
versus 1.5 ± 0.2 pmol/million cells). This treatment increased
Ang-2 mRNA level more than 3-fold compared to 5 mM glu-
cose (Figure 1A). Since overproduction of superoxide by mi-
tochondria is the major mechanism by which hyperglycemia
increases intracellular levels of the glyoxalase I substrate
methylglyoxal (Brownlee, 2001), we also evaluated the effect
of overexpressing either uncoupling protein-1 (UCP-1),
a specific protein uncoupler of oxidative phosphorylation ca-
pable of collapsing the proton electrochemical gradient, or
manganese superoxide dismutase (MnSOD), the mitochon-
drial form of this antioxidant enzyme. Protein levels were in-
creased 2.7-fold for GLO1, 1.9-fold for UCP-1, and 2.3-fold
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lar methylglyoxal concentration and completely prevented
the hyperglycemia-induced increase of Ang-2 mRNA. Iden-
tical results were obtained for Ang-2 protein levels (Fig-
ure 1B). GLO1 siRNA treatment of cells incubated in low glu-
cose increased both Ang-2 transcription activity and Ang-2
protein level to that induced by high-glucose flux (data not
shown).
We next examined the effect of glyoxalase I overexpres-
sion on hyperglycemia-induced expression of Ang-2 using
a reporter construct containing 2.5 kb of mouse Ang-2
genomic 50 flanking region (2301 to +183) fused to the lu-
ciferase gene (Maisonpierre et al., 1997). Thirty millimolar
glucose treatment increased luciferase activity 2.7-fold com-
pared to that of 5 mM glucose (Figure 1C). Overexpression of
GLO1, UCP-1, and MnSOD each prevented hyperglycemia-
induced increase of transcriptional activity. Incubating cells
in medium containing 10 mM methylglyoxal for either 60
min or for 24 hr did not increase Ang-2 expression (data
not shown).
Identification of a Glucose-Responsive Element
in the Ang-2 Promoter
To localize the regulatory elements required for transcrip-
tional activation of the Ang-2 gene by hyperglycemia, pro-
gressive 50 promoter deletion constructs were generated
containing different portions of the Ang-2 promoter. In
5 mM glucose, the reporter activities were not markedly
different among the 2301, 1983, 1283, 993, 739,
and 213 deletion constructs. However, a significant de-
crease of activity was observed in the 33 construct com-
pared to the213 construct. In 30 mM glucose, the activities
were increased approximately 2.5-fold compared to those
in 5 mM glucose in all constructs. With the 33 construct,
hyperglycemia had no effect. These data indicate that
promoter elements between 213 and 33 are responsible
for hyperglycemia-induced transcriptional activation of
the Ang-2 promoter (Figure 1E). Comparison of these se-
quences with transcription factor databases (TFSEARCH) re-
vealed two c-Ets sites (positions 193 and 164), an AP-1
site (173), an AP-2 site (144), and an Sp1 site (139)
(Figure 1F).
We next explored the possible involvement of these motifs
in the hyperglycemia- induced increase in transcriptional ac-
tivity of the Ang-2 promoter using a series of mutated or de-
leted Ang-2 luciferase constructs. As shown in Figure 1F,
deletion of the distal c-Ets (position 193) revealed no de-
crease in hyperglycemia-induced transcriptional activation.
Similarly, mutation of the AP-1 site (construct 174 + AP-1
mut), the proximal c-Ets site (position 164) or deletion of
sequence upstream of nt 157 (construct 157) also had
no effect. In contrast, mutation of the GC-rich sequences be-
tween the AP-2 and Sp1 site (174 + GC mut and 164 +
GC mut), and deletion of sequence upstream of nt 114
each caused complete inhibition of hyperglycemia-induced
activation. These data indicated that the GC-rich sequence
between the AP-2 and Sp1 site is required for glucose-re-
sponsiveness of the Ang-2 promoter.
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Figure 1. Glyoxalase I Overexpression Prevents Increased Ang-2 Production Induced by a Glucose-Responsive GC Box
rMC-1 cells were incubated for 5 days in 5 mM glucose (LG), 30 mM glucose (HG), or HG after infection with UCP-1, MnSOD, GLO1, or empty (VEC)
adenoviral vectors.
(A) Ang-2 mRNA was amplified and quantified by real-time PCR (qPCR).
(B) Ang-2 protein was detected by Western blotting and quantified.
(C) Mouse Ang-2 reporter construct (mAng-2) was transfected into rMC-1 cells, and transcriptional activity was calculated from luciferase assay. Data in (A)–
(C) are expressed as mean ± SEM of three independent experiments. *p < 0.01 versus LG group.
(D) Representative Western blots of UCP-1, MnSOD, and GLO1 in wild-type cells (wt) and in cells infected with the indicated adenoviral vectors (Adeno).
(E) rMC-1 cells were transfected with the indicated 10 mg of progressive 50 promoter deletion or mutant reporter constructs, incubated in 5 mM (LG) or 30
mM (HG) glucose for 48 hr, and Ang-2 transcriptional activity was calculated from luciferase activity. *p < 0.01 versus mAng-2 -2301 HG.
(F) rMC-1 cells were transfected with the indicated Ang-2 promoter reporter constructs, and transcriptional activity was determined. *p < 0.01 versus mAng-
2-194 HG. Data in (E) and (F) are expressed as mean ± SEM of three independent experiments.
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Sp3 and Sp1 Binding to the Ang-2 Promoter Changes
in Response to High Glucose
To determine which of these nuclear proteins binds to the
GC-box site and what the effects of hyperglycemia and
glyoxalase I overexpression are in the context of native chro-
matin structure, chromosomal immunoprecipitation (ChIP)
analysis was performed using antibodies specific for the in-
dicated cognate proteins shown in Figure 2. After immuno-
precipitation and reversal of the crosslinking, the endoge-
nous Ang-2 promoter was enriched by real-time PCR
amplification using primers specific for the Ang-2 GC box
site. The PCR product from Sp1 immunoprecipitation was
increased 1.7-fold by 30 mM glucose compared to 5 mM
glucose, and this increase was prevented by overexpression
of GLO1, as well as by overexpression of UCP-1 or MnSOD
(Figure 2A). In contrast, the PCR product from Sp3 immuno-
precipitation was decreased 1.8-fold in 30 mM glucose
compared to 5 mM (Figure 2B). This decrease was pre-
vented by overexpression of GLO1, as well as by overex-
pression of UCP-1 or MnSOD. AP-2a binding was not af-
fected (Figure 2C). These data indicated that Sp1, Sp3,
and AP-2a bind to the Ang-2 promoter in the context of its
native chromatin structure and suggested that the observed
changes in Sp1 and Sp3 binding induced by incubating cells
in 30 mM glucose mediated high-glucose-induced Ang-2
expression.
Sp3 Complexes with Methylglyoxal-Modified
Proteins, but Neither Sp3 nor Sp1 Is Modified
by Methylglyoxal
Since GLO1 overexpression prevented hyperglycemia-in-
duced changes in Sp1 and Sp3 binding to the glucose-re-
sponsive element in the Ang-2 promoter (Figure 2), we hy-
pothesized that hyperglycemia induced these changes by
modifying either Sp1, Sp3, or both with methylglyoxal. To
demonstrate this, we first immunoprecipitated nuclear ex-
tracts from rMC-1 cells with anti-MG antibody and immuno-
blotted for Sp1, Sp3, and mSin3A (Figure 3A). Neither hyper-
glycemia nor GLO1 overexpression affected Sp1 band
density. In contrast, hyperglycemia increased the density
of the Sp3 band, and GLO1 overexpression prevented this
increase. The hyperglycemia-induced increase in Sp3
band density was also prevented by overexpression of
UCP-1 and MnSOD. Surprisingly, however, when Sp1 and
Sp3 were immunoprecipitated and then immunoblotted
with anti-MG, neither protein was modified by MG (data
not shown). These results suggested that an Sp3-associ-
ated protein was modified by methylglyoxal, rather than
Sp3 itself, and that this modification might alter Sp3 binding
to the Ang-2 promoter.
Methylglyoxal Modifies mSin3A, which Increases
Its Association with OGT
Since a variety of proteins have been reported to associate
with Sp3, we performed IP Western blots for HDAC1/2,
RbAp46/48, N-CoR, OGT (data not shown), and mSin3A.
Only the corepressor mSin3A was modified by MG (Figures
3A and 3B). Cells incubated in high glucose had a 2.7-fold
RE
TR278 Cell 124, 275–286, January 27, 2006 ª2006 Elsevier Inc.increase in MG modification of mSin3A. Overexpression of
GLO1, as well as UCP-1 and MnSOD, prevented this in-
crease. Cells incubated in low glucose after transfection
with GLO1-RNAi showed an increase in MG modification
of mSin3A similar to that observed with high glucose (see
Figure 2. High Glucose Decreases Binding of Sp3 and
Increases Binding of Sp1 to the Ang-2 Promoter In Vivo
rMC-1 cells were incubated as described in Figure 1. Soluble chromatin
was prepared from rMC-1 cells, followed by immunoprecipitation with an-
tibodies to Sp1, Sp3, and AP-2a. The DNA extracted from the respective
immunoprecipitates was amplified by real-time PCR (qPCR) using
primers that amplify the glucose-responsive element in the rat Ang-2 pro-
moter. Input represents each PCR product from 2% of the preimmuno-
precipitated DNA. Representative bands and qPCR results are shown
for ChIP using antibodies to Sp1 (A), Sp3 (B), AP2a (C), and Input (D).
Data are expressed as mean ± SEM of three independent experiments.
*p < 0.01 versus LG group.
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Figure 3. Glucose-Derived Methylglyoxal Modifies mSin3A at R925 and K938, which Increases Its Association with OGT
rMC-1 cells were incubated as described in Figure 1.
(A) Nuclear extracts were immunoprecipitated (IP) with antibodies to the major intracellular methylglyoxal-derived epitope, Na-acetyl-Nd-(5-hydro-5-
methyl)- 4-imidazolone (MG), and immunoblotted (IB) with antibodies to Sp1, Sp3, and mSin3A.
(B) Nuclear extracts were immunoprecipitated (IP) with antibodies to mSin3A and immunoblotted (IB) with antibodies to MG, OGT, or mSin3A.
(C) Nuclear extracts were immunoprecipitated (IP) with antibodies to OGT and immunoblotted (IB) with antibodies to mSin3A or OGT. Ten percent of nuclear
extracts were immunoblotted (IB) for MG (data not shown), b-actin, mSin3A, or OGT as input. Experiments were repeated three times, and the band density
was quantified by IMAGEQUANT.
(D) Amino acid sequence for mouse mSin3A PAH4 domain (aa 888–955). Potential MG-responsive sites are colored red for arginine (R), blue for lysine (K),
and green for cysteine (C).
(E) IP of wt mSin3A and mSin3A/925+938 (Q) with WB for MG. rMC-1 cells were transfected with the indicated constructs, incubated in either LG or HG, and
blotted with the indicated antibodies. The membrane was scanned and quantitated by the ODYSSEY Infrared Imaging System.
(F) WB of Ang-2 from rMC-1 cells transfected with either mSin3A/wt or mSin3A/925+938 (Q) and incubated in low or high glucose for 5 days. The membrane
was scanned and quantitated by the ODYSSEY Infrared Imaging System.
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Figure S1 in the Supplemental Data available with this article
online).
mSin3A has been reported to recruit the enzyme
O-GlcNAc transferase (OGT; Yang et al., 2002). When im-
munoprecipitated mSin3A was immunoblotted for OGT,
cells incubated in high glucose had significantly more OGT
associated with mSin3A (Figure 3B). Overexpression of
GLO1, as well as UCP-1 and MnSOD, prevented this in-
crease. This effect was confirmed by immunoprecipitating
OGT and then immunoblotting for mSin3A (Figure 3C).
To determine which MG-modifiable residues in mSin3A
were required for this increased binding of OGT, we first
showed that the PAH4 domain of mSin3A was both neces-
sary and sufficient for this methylglyoxal-responsive recruit-
R ment by subcloning different mSin3A domains (aa 1–189[PAH1], AA 189–383 [PAH2], aa 383–526 [PAH3], aa 526–888 [HID], aa 888–955 [PAH4], and aa 955–1219) into thepVP16-AD-vector for mammalian two-hybrid assays with
pM-DBD-OGT (1–286) (data not shown). These data are
consistent with data reported by Yang et al. (2002) showing
that the PAH4 domain of mSin3A was necessary and suffi-
cient for binding OGT. Although methylglyoxal reacts primar-
ily with Arg (R) residues in vivo, Lys (K) and Cys (C) residues
in proteins can also be modified (Chaplen et al., 1998; Van
Herreweghe et al., 2002). We therefore evaluated the pos-
sible role of each R, K, and C residue in the PAH4 domain
of mSin3A (Figure 3D) by making point mutants in the
PAH4 domain that converted each of the 14 residues toCell 124, 275–286, January 27, 2006 ª2006 Elsevier Inc. 279
glutamine (Q). Mammalian two-hybrid assays showed that
overexpression of GLO1 completely prevented the in-
creased association of mSin3A with OGT induced by high
glucose (Figure S2). Single mutations of R923, R925, and
K938 partly prevented the increased association of mSin3A
and OGT, and double mutation of R925 and K938 com-
pletely prevented the increased association. Double muta-
tion of R923 and R925 was no more effective than mutation
of R925 alone, and double mutation of R923 and K938
was slightly more effective than mutation of K938 alone
(Figure S2).
These results are consistent with receptor binding domain
(RBD) analysis from the PAH4 domain sequence data
(Figure S3), which identified six methylglyoxal-modifiable
residues as potential sites critical for protein-protein interac-
tion (R916, R923, R925, R936, R947, and K938).
The effect of the double mutation on high-glucose-in-
duced modification of mSin3A by methylglyoxal was evalu-
ated directly by IP:WB after overexpression of either wt or
mutant mSin3A (Figure 3E). Incubation in high glucose
caused a 2.5-fold increase in MG modification of full-length
wt mSin3A. In contrast, the double mutant mSin3A/
925+938 (Q) showed no increase in MG modification in-
duced by incubation in high glucose. Using a two-color infra-
red fluorescent detection system, mSin3A and MG immuno-
reactivity were shown to colocalize.
Loss of functionality of the mSin3A double mutant was
demonstrated by identical experiments in which the effect
of high glucose on Ang-2 expression was assessed (Fig-
ure 3F). High-glucose incubation of cells overexpressing wt
mSin3A increased Ang-2 expression by 2.9-fold, while
high-glucose incubation of cells overexpressing mSin3A/
925+938 (Q) had no effect on Ang-2 expression.
Association of Sp3 with OGT Causes Sp3
Glycosylation
To directly demonstrate that increased methylglyoxal con-
centrations induced by high-glucose flux caused increased
association of Sp3 with OGT, nuclear extracts were immu-
noprecipitated with anti-Sp3, and then immunoblotted for
OGT and O-GlcNAc (Figure 4A). High glucose increased as-
sociation of Sp3 with OGT and also increased modification of
Sp3 by O-GlcNAc. Overexpression of GLO1, as well as
UCP-1 and MnSOD, prevented both of these increases.
These results were confirmed by immunoprecipitation with
anti-O-GlcNAc and immunoblotting for Sp3 (Figure 4B).
Methylglyoxal Modification of mSin3A Decreases
Sp3 and mSin3A Binding to the Ang-2 Promoter
To determine whether the high-glucose-induced changes
described thus far do in fact reduce binding of Sp3 and
mSin3A and increase binding of Sp1 to the Ang-2 promoter
GC box, we performed DNA affinity precipitation assays
(DAPA). Nuclear extracts were precipitated by double-
stranded nucleotides corresponding to the Ang-2 promoter
GC box and immunoblotted for Sp3, mSin3A, and Sp1 (Fig-
ure 5). High glucose reduced binding of both Sp3 and
mSin3A by 2-fold but increased binding of Sp1. Overexpres-
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high-glucose-induced changes in binding of these proteins
to the Ang-2 promoter GC box.
Sp3 Glycosylation Causes Decreased Binding
of Sp3/mSin3A/OGT Complex to the Ang-2
Promoter, and Binding Can Be Restored
by Inhibiting Glycosylation
To determine directly whether modification of Sp3 by OGT is
critical for decreased binding of the Sp3/mSin3A complex to
the Ang-2 promoter GC box, we used antisense to inhibit the
rate-limiting enzyme of UDP-GlcNAc formation, glutamine:
fructose-6-phosphate amidotransferase (GFAT). Inhibition
of this enzyme prevents O-GlcNAc modification of proteins
by OGT (Du et al., 2001; Wells and Hart, 2003). As shown
in Figure 6A, GFAT antisense, which reduced GFAT mRNA
by 61%, completely prevented the increased modification
of Sp3 by O-GlcNAc caused by high-glucose flux. Critical
for our hypothesis, GFAT antisense also prevented both
the decreased binding of Sp3 and mSin3A and the increased
binding of Sp1 to the Ang-2 promoter GC box (Figure 6B). To
further demonstrate that Sp3 glycosylation decreases its
binding to the Ang-2 promoter GC box, we overexpressed
Figure 4. Glyoxalase I Overexpression Prevents Increased
Association of Sp3 with OGT, and Consequent Increased
Modification of Sp3 by O-GlcNAc
rMC-1 cells were incubated as described in Figure 1.
(A) Nuclear extracts were immunoprecipitated (IP) with antibodies to Sp3
and immunoblotted (IB) with antibodies to OGT, or O-GlcNAc-modified
protein.
(B) Nuclear extracts were immunoprecipitated (IP) with antibodies to
O-GlcNAc and immunoblotted (IB) with antibody to Sp3. Ten percent of
nuclear extracts were immunoblotted with antibodies to Sp3, b-actin,
or O-GlcNAc-modified protein (data not shown) as input. Experiments
were repeated three times, and the band densities were quantified by
IMAGEQUANT.
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a soluble enzyme specific for the removal of O-GlcNAc from
proteins, O-b-N-acetylglucosaminidase (O-GlcNAcase;
Dong and Hart, 1994), in cells incubated in high glucose.
This overexpression (confirmed by His-tag Western blotting)
completely prevented the increased modification of Sp3 by
O-GlcNAc caused by high-glucose flux (Figure 6C), and
like AS-GFAT, it also prevented both the decreased binding
of Sp3 and mSin3A and the increased binding of Sp1 to the
Ang-2 promoter GC box (Figure 6D). Finally, we incubated
cells in 5 mM glucose in the presence of a specific inhibitor
of O-GlcNAcase, PUGNAc (Horsch et al., 1991). PUGNAc
treatment of cells incubated in 5 mM glucose increased
Sp3 modification by O-GlcNAc to the same extent as high
glucose (Figure 6C). Concomitantly, PUGNAc treatment of
cells incubated in 5 mM glucose also decreased binding of
Sp3 and mSin3A and increased binding of Sp1 to the Ang-2
promoter GC box to the same extent as high glucose
(Figure 6D).
DISCUSSION
In the present study, we describe a novel mechanism for reg-
ulating gene expression: regulatory protein modification by
the glycolysis-derived dicarbonyl metabolite methylglyoxal.
We demonstrate that in retinal Mu¨ller cells, increased glyco-
lytic flux causes increased methylglyoxal modification of the
corepressor mSin3A. Methylglyoxal modification of mSin3A
results in increased recruitment of O-GlcNAc transferase to
an mSin3A/Sp3 complex, with consequent increased mod-
ification of Sp3 by O-linked N-acetylglucosamine. This mod-
Figure 5. High Glucose Decreases Binding of Sp3 and
mSin3A but Increases Binding of Sp1 to the Ang-2 Promoter
rMC-1 cells were incubated as described in Figure 1. Nuclear extracts
were precipitated in a DAPA assay using a double-strand oligonucleotide
containing the Ang-2 promoter GC box and immunoblotted (IB) with
antibodies against Sp3, mSin3A, and Sp1. Ten percent of nuclear ex-
tracts were immunoblotted for b-actin as input control. The experiments
were repeated three times, and the band densities were quantified by
IMAGEQUANT.
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complex to a glucose-responsive GC box in the angiopoie-
tin-2 promoter, resulting in increased Ang-2 expression.
These findings are shown schematically in Figure 7.
The mSin3A Corepressor Is Regulated
by Methylglyoxal
mSin3A is a large protein with multiple protein-protein inter-
action domains (Kuzmichev et al., 2002; Skowyra et al.,
2001). It functions as a corepressor for a number of tran-
scriptional repressors (Ahringer, 2000; Knoepfler and Eisen-
man, 1999). The core mSin3A corepressor complex appears
to involve associated histone deacetylases HDAC1/2
(Hassig et al., 1997; Laherty et al., 1997) and linking proteins
(Zhang and Dufau, 2002). Only mSin3A itself was modified
by methylglyoxal in our studies. It is possible, however, that
very low levels of methylglyoxal modification on other pro-
teins may not have been detectable. Using a mammalian
two-hybrid assay, we found that the mSin3A paired amphi-
pathic helix 4 (PAH4) domain was necessary and sufficient
for increased association of methylglyoxal-modified mSin3A
with O-GlcNAc transferase. Within the PAH4 domain, muta-
tion of R925 markedly impaired this increased association,
while mutation of R923 or K938 had smaller effects. Double
mutation of R925 and K938 completely prevented the in-
creased association, while double mutation of R923 and
R925 was no more effective than mutation of R925 alone.
The arginine and lysine residues most reactive with methyl-
glyoxal are those with proximate arginine and lysine residues
that decrease the pKa of both interacting amino groups and
a glutamic acid or aspartic acid carboxylate side chain on
the alternate side in the sequence to act as a catalytic
base (Ahmed et al., 2005; Venkatraman et al., 2001). As-
suming helical configuration of the nonproline sequences
in PAH4, R925 is activated for methylglyoxal modification
by the effects of both R929 and E921. The other arginine
residues in PAH4 lack one or both of these activating influ-
ences—including R923 and R929, which have only basic
and cationic activating groups, respectively. The modest
functional effect of mutated R923 and its nonadditive effect
in the double mutant R923+R925 suggest that R923 may
mediate effects on PAH4-OGT binding through reorienta-
tion of R925. R923 has proximity to W927 in a helix config-
uration, with the formation of a strong cation-p bonding
interaction (Crowley and Golovin, 2005). Disruption of this
interaction would relax the helix, which could change the ori-
entation of R925. In the R923+R925 double mutant, this
effect would be redundant. K938 has both two proximate
basic and one cationic activating group, while the other
two lysine residues in the PAH4 domain do not. mSin3A
has been shown to recruit the enzyme OGT to promoters
in a several tumor cell lines, which then acts in concert
with histone deacetylation to promote gene silencing
(Yang et al., 2002). In contrast, our data in retinal Mu¨ller cells
show that recruitment of OGT to mSin3A activates, rather
than represses, gene expression, when the mSin3A is mod-
ified by methylglyoxal arising from high-glucose flux and
CT
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Figure 6. Increased Sp3 Glycosylation and Decreased Binding of Sp3 and mSin3A to the Ang-2 Promoter are Restored by Either
Inhibition of UDP-GlcNAc Formation or Increased Removal of O-Linked N-Acetylglucosamine
(A) rMC-1 cells were incubated in LG, HG, or HG after transfection with either GFAT antisense (HG + AS-GFAT) or scrambled oligonucleotides (HG + SCR).
Nuclear extracts were immunoprecipitated (IP) with antibodies to Sp3, then immunoblotted (IB) with antibodies against O-GlcNAc-modified protein. GFAT
mRNA level was analyzed by real-time PCR to verify GFAT antisense effect (data not shown).
(B) Nuclear extracts from the above treated cells were precipitated by a double-strand oligonucleotide containing the Ang-2 promoter GC box and immu-
noblotted with antibodies against Sp3, mSin3A, and Sp1.
(C and D) Cells were incubated in LG, HG, HG after transfection of His-tagged O-GlcNAcase, or LG plus the OGT-inhibitor PUGNAc. Transfection was
confirmed by WB with His antibody.
(C) IP:IB analysis was performed as described in (A).
(D) DAPA was performed as described in (B).
(A–D) Ten percent of nuclear extracts were immunoblotted for Sp3 or b-actin as input control. The experiments were repeated three times, and the band
densities were quantified by IMAGEQUANT.
RA
CT
EDreactive oxygen species formation by the mitochondrial
electron transport chain.
Regulation of Other Factors by Methylglyoxal
It has been suggested that in Saccharomyces cerevisiae,
methylglyoxal reversibly modifies cysteine residues in the
transcription factor Yap1, causing nuclear localization and
activation (Maeta et al., 2004). Glyoxalase I-deficient mu-
tants showed increased Yap1 activation. However, in these
experiments, no measurements of methylglyoxal-derived
adducts on cellular proteins were performed. Thus, neither
methylglyoxal modification of Yap1 nor modification of pro-
teins interacting with or signaling to Yap1 was directly dem-
onstrated. Incubation of S. cerevisiae with an 80,000-fold
higher concentration of methylglyoxal than that found in
Mu¨ller cell medium activated Yap1, but this high concentra-
tion of exogenous methylglyoxal almost certainly modified
many cell surface proteins, which may have affected Yap1
activation. In our Mu¨ller cell experiments, incubation with
100 times the concentration of methylglyoxal found in Mu¨ller
cell medium had no effect on Ang-2 transcription.
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mSin3A binding with the ubiquitous transcription factor Sp3
has not been reported previously. Sp3 and Sp1 compete for
common GC-rich target sequences in promoter elements (Li
et al., 2004; Suske, 1999). Although both Sp3 and Sp1 may
act as inhibitors or activators of gene expression, Sp3 has
been found to repress Sp1-mediated transcriptional activa-
tion in a number of cell types (Ghayor et al., 2001; Hagen
et al., 1994). The function of Sp1 depends on promoter con-
text, recruitment of transcription-modifying factors such as
the chromatin-remodeling SWI/SNF family proteins for Sp1
transactivation (Lu et al., 2003) and a variety of posttransla-
tional modifications (Li et al., 2004).
Glycosylation of Transcription Factors as a General
Regulatory Mechanism
Modification of nearly all RNA polymerase II-dependent
transcription factors on serine and threonine residues by
O-linked N-acetylglucosamine is a dynamic process, analo-
gous to phosphorylation/dephosphorylation. The glyco-
sylation status is regulated by the relative activities of the
Figure 7. Model for Transcriptional Regulation by Glucose-Derived Methylglyoxal
(A) Under basal conditions, complexes of Sp3 and mSin3A bind to the GC box in the Ang-2 promoter and inhibit Ang-2 transcription.
(B) Increased glucose-derived methylglyoxal (MG) causes increased mSin3A modification.
(C) Increased MG-modification of mSin3A increases association of O-GlcNAc transferase (OGT) with the bound complex.
(D) Increased glucose-derived UDP-N-acetylglucosamine (UDP-GlcNAc) is transferred to Sp3 by bound OGT.
(E) Increased Sp3 modification by O-GlcNAc causes decreased binding affinity to the GC box, and altered DNA partitioning of the Sp3-mSin3A-OGT
complex.
(F) The decrease of bound Sp3 allows more Sp1 to bind to the GC box, activating Ang-2 transcription.R
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EDenzymes O-b-N-acetylglucosaminyltransferase (OGT) and
O-b-N-acetylglucosaminidase (O-GlcNAcase; Kamemura
and Hart, 2003). O-GlcNAcylation of Sp1 may stimulate or
repress transcription (Du et al., 2000; Kang et al., 2003;
Roos et al., 1997; Yang et al., 2001), most likely depending
on which residues are modified. In 293 cells and SL2 cells,
Sp3 was not modified by O-GlcNAc, as determined by
wheat germ agglutinin affinity chromatography (Sapetschnig
et al., 2004). However, the effect of increased glucose flux on
O-GlcNAc modification of Sp3 was not evaluated.
OGT has also been shown to modify the 26S, but not the
20S, proteasome, thereby reducing the processing of Sp1
(Zachara and Hart, 2004; Zhang et al., 2003). Although the
relative rates of Sp1 degradation were not evaluated in our
Mu¨ller cell system, we found no change in total Sp1 protein
levels with increased glucose flux. Methylglyoxal-modified
mSin3A increases O-GlcNAcylation of Sp3 by recruiting
OGT. Increased Sp3 O-GlcNAcylation decreases the bind-
ing affinity of the mSin3A/Sp3 complex to the glucose-re-
sponsive GC box in the Ang-2 promoter, allowing more
Sp1 binding to the same site and resulting in increased pro-
RE
T moter activity. This effect was replicated in cells cultured inlow glucose by increasing Sp3 modification with an inhibitor
of O-GlcNAcase. Similarly, this effect was inhibited in cells
cultured in high glucose, by decreasing Sp3O-GlcNAc mod-
ification with an O-GlcNAcase expression vector.
Concluding Remarks
Regulation of gene expression involves complex interactions
among histones, transcription factors, coactivators, and co-
repressors. An emerging concept is that coactivator and co-
repressor proteins may be primary targets of physiologic sig-
nals, coordinating distinct biological programs (Lin et al.,
2004). Posttranslational modifications of coactivator proteins
have been described (Chakraborty et al., 2001; Fingerman
and Briggs, 2004), which are thought to regulate coactivator
function. Our studies demonstrate for the first time that
methylglyoxal causes posttranslational modification of a co-
regulator protein, which affects gene expression. The extent
of this modification reflects the net effect of a variety of intra-
cellular processes, including metabolic flux and reactive ox-
ygen formation, and may thus function as a new integratingCell 124, 275–286, January 27, 2006 ª2006 Elsevier Inc. 283
signal to coordinately regulate distinct patterns of gene ex-
pression.
EXPERIMENTAL PROCEDURES
Promoter Constructs, siRNA, and Antisense Oligonucleotides
For mapping of the glucose-responsive element of the Ang-2 promoter,
the indicated deletion promoter constructs were generated by PCR
methods and the indicated mutations were generated using the Site-di-
rected Mutagenesis Kit from Promega. All constructs were verified by se-
quencing.
GLO1 siRNA (siRNA ID, 201923) for rat was obtained from Ambion.
GFAT phosphorothioate S-antisense oligonucleotides (50-CCA CCT
GCA AGA CCA TCG-30) and scrambled control oligonucleotides were
synthesized by Operon Technologies Inc.
RT Reaction and Real-Time Quantitative PCR
Total RNA from treated cells was extracted using the RNeasy Mini Kit
(Qiagen), and the RNA was reverse transcribed by SuperScript III First
Strand Synthesis System (Invitrogen). Real-time quantitative PCR
(qPCR) was run on a Lightcycler (Roche Molecular Systems) with the
LightCycler FastStart DNA Master SYBR Green I kit (Roche). Optimization
of PCR was performed until the efficiency of the PCR was in the range of
0.99 1. PCR was performed by denaturing at 95ºC for 7min, followed by
45 cycles of denaturation at 95ºC, annealing at 60ºC, and extension at
72ºC for 30s, respectively. The oligonucleotide templates were diluted
in the range of 109  105 mM for each standard curve. A 1:200 dilution
of cDNA was used to measure 18S rRNA, and 1 ml of 1:10 dilution of each
cDNA was used to measure target genes. Results were normalized by
18S rRNA.
Immunoprecipitation (IP) and Western Blotting (WB)
Cell lysates or nuclear extracts were precleared by preimmune IgG plus
protein A agarose beads for 2 hr, and the supernatants were immunopre-
cipitated by the indicated antibodies and a 50% slurry of protein A aga-
rose beads overnight at 4ºC (Metivier et al., 2003). After washing with
buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl, 1% NP-40, and
0.5% deoxycholate with protease inhibitors, proteins were released, sep-
arated on 10% SDS-PAGE gels, and blots were developed with ECF
Western Blotting Reagent Packs (Amersham). Bands were scanned by
Molecular Devices STORM 860, quantified by IMAGEQUANT, and nor-
malized to b-actin. No bands were observed after immunoprecipitation
with preimmune IgG (data not shown).
Intracellular Methylglyoxal Measurement
Cellular concentrations of MG were determined by liquid chromatogra-
phy-tandem mass spectrometry (LC-MS/MS) with internal standardiza-
tion of [13C3]MG-substituted standards, as previously described, using
a Micromass Quattro Ultima triple quadrupole mass spectrometric detec-
tor (Waters-Micromass; Ahmed et al., 2005).
Chromatin Immunoprecipitation (ChIP)
Chromatin was crosslinked using 1% formaldehyde for 20 min at 22ºC
and terminated by addition of 0.1 M glycine. Cell lysates were sonicated
and centrifuged. Five hundred micrograms protein were precleared by
BSA/salmon sperm DNA plus preimmune IgG and a slurry of protein A
agarose beads as previously described (Metivier et al., 2003). Immuno-
precipitations were performed with the indicated antibodies, BSA/salmon
sperm DNA, and a 50% slurry of protein A agarose beads. Input and im-
munoprecipitates were washed and eluted, then incubated for 2 hr at
42ºC followed by 6 hr at 65ºC to reverse the formaldehyde crosslinking.
DNA fragments were recovered by Proteinase K treatment followed by
phenol/chloroform extraction and ethanol precipitation. A 201 bp frag-
ment from the rat Ang-2 promoter (nt 213 to nt 13) was amplified by
real-time PCR (qPCR). No bands were observed after immunoprecipita-
tion with preimmune IgG (data not shown).
RE
TR284 Cell 124, 275–286, January 27, 2006 ª2006 Elsevier Inc.Two-Color Infrared Imaging of Western Blots
Cell supernatants were immunoprecipitated by the indicated primary an-
tibodies and then simultaneously incubated with the differentially labeled
species-specific secondary antibodies, anti-RABBIT IRDye 800CW
(green) and anti-MOUSE ALEXA680 (red). Membranes were scanned
and quantitated by the ODYSSEY Infrared Imaging System (LI-COR, NE).
DNA Affinity Precipitation Assay (DAPA)
Biotin labeled oligonucleotide 50-agt ggg tga gcc agg ggg cgg agc ggc
tgg ctg c-30 and its antisense were annealed and purified. Two hundred
micrograms nuclear extracts in binding buffer (60 mM KCl, 12 mM HEPES
[pH 7.9], 4 mM Tris-HCl [pH 7.5], 5% glycerol, 0.5 mM EDTA, 1 mM DTT
and protease inhibitors) were precleared by 3 mg of scrambled double-
strand DNA supplemented with preequilibrated Tetralink Avidin Resin
(Promega). The precleared nuclear extracts were further incubated with
2 mg of DAPA probe at 4ºC for 1 hr with gentle rotation, then 20 ml pre-
equilibrated Tetralink Avidin Resin was added to incubate for another
1hr. Beads were pelleted and washed with buffer, then boiled for 5 min
in SDS-PAGE gel loading buffer for Western blotting analysis.
Supplemental Data
Supplemental Data include three figures and Supplemental Experimental
Procedures and can be found with this article online at http://www.cell.
com/cgi/content/full/124/2/275/DC1/.
ACKNOWLEDGMENTS
These studies were supported by grants from the National Institutes of
Health (DK 33861 and AG 021654) to M.B. and to the Albert Einstein Col-
lege of Medicine Diabetes Research and Training Center (DK 20541) and
by grants from the Juvenile Diabetes Research Foundation (4-2004-804)
to M.B. We are grateful for the generosity of Drs. G.D. Yancopoulos and
P.C. Maisonpierre for the pGL3-mANG-2(short)-Luc reporter plasmid, Dr.
R.M. Evans for mouse Gal4mSin3A, Dr. G.W. Hart for rat OGT cDNA,
OGT antibody, and human His-tagged GlcNAcase cDNA. We thank Dr.
L. Rossetti for his critical reading of this manuscript.
Received: May 29, 2005
Revised: September 13, 2005
Accepted: November 1, 2005
Published online: January 12, 2006
REFERENCES
Agalou, S., Ahmed, N., Dawnay, A., and Thornalley, P.J. (2003). Removal
of advanced glycation end products in clinical renal failure by peritoneal
dialysis and haemodialysis. Biochem. Soc. Trans. 31, 1394–1396.
Ahmed, N., and Thornalley, P.J. (2003). Quantitative screening of protein
biomarkers of early glycation, advanced glycation, oxidation and nitrosa-
tion in cellular and extracellular proteins by tandem mass spectrometry
multiple reaction monitoring. Biochem. Soc. Trans. 31, 1417–1422.
Ahmed, N., Dobler, D., Dean, M., and Thornalley, P.J. (2005). Peptide
mapping identifies hotspot site of modification in human serum albumin
by methylglyoxal involved in ligand binding and esterase activity. J. Biol.
Chem. 280, 5724–5732.
Ahringer, J. (2000). NuRD and SIN3 histone deacetylase complexes in
development. Trends Genet. 16, 351–356.
Beisswenger, P.J., Howell, S.K., Nelson, R.G., Mauer, M., and Szwer-
gold, B.S. (2003). Alpha-oxoaldehyde metabolism and diabetic complica-
tions. Biochem. Soc. Trans. 31, 1358–1363.
Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic
complications. Nature 414, 813–820.
Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9,
653–660.
AC
TE
D
Chakraborty, S., Senyuk, V., and Nucifora, G. (2001). Genetic lesions and
perturbation of chromatin architecture: a road to cell transformation.
J. Cell. Biochem. 82, 310–325.
Chaplen, F.W., Fahl, W.E., and Cameron, D.C. (1998). Evidence of high
levels of methylglyoxal in cultured Chinese hamster ovary cells. Proc.
Natl. Acad. Sci. USA 95, 5533–5538.
Creighton, D.J., Zheng, Z.B., Holewinski, R., Hamilton, D.S., and Eise-
man, J.L. (2003). Glyoxalase I inhibitors in cancer chemotherapy. Bio-
chem. Soc. Trans. 31, 1378–1382.
Crowley, P.B., and Golovin, A. (2005). Cation-pi interactions in protein-
protein interfaces. Proteins 59, 231–239.
Dong, D.L., and Hart, G.W. (1994). Purification and characterization of an
O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen
cytosol. J. Biol. Chem. 269, 19321–19330.
Du, X.L., Edelstein, D., Rossetti, L., Fantus, I.G., Goldberg, H., Ziyadeh,
F., Wu, J., and Brownlee, M. (2000). Hyperglycemia-induced mitochon-
drial superoxide overproduction activates the hexosamine pathway and
induces plasminogen activator inhibitor-1 expression by increasing Sp1
glycosylation. Proc. Natl. Acad. Sci. USA 97, 12222–12226.
Du, X.L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., and Brownlee, M.
(2001). Hyperglycemia inhibits endothelial nitric oxide synthase activity
by posttranslational modification at the Akt site. J. Clin. Invest. 108,
1341–1348.
Du, X., Matsumura, T., Edelstein, D., Rossetti, L., Zsengeller, Z., Szabo,
C., and Brownlee, M. (2003). Inhibition of GAPDH activity by poly(ADP-
ribose) polymerase activates three major pathways of hyperglycemic
damage in endothelial cells. J. Clin. Invest. 112, 1049–1057.
Fingerman, I.M., and Briggs, S.D. (2004). p53-mediated transcriptional
activation: From test tube to cell. Cell 117, 690–691.
Gale, N.W., Thurston, G., Hackett, S.F., Renard, R., Wang, Q., McClain,
J., Martin, C., Witte, C., Witte, M.H., Jackson, D., et al. (2002). Angiopoie-
tin-2 is required for postnatal angiogenesis and lymphatic patterning, and
only the latter role is rescued by Angiopoietin-1. Dev. Cell 3, 411–423.
Ghayor, C., Chadjichristos, C., Herrouin, J.F., Ala-Kokko, L., Suske, G.,
Pujol, J.P., and Galera, P. (2001). Sp3 represses the Sp1-mediated trans-
activation of the human COL2A1 gene in primary and de-differentiated
chondrocytes. J. Biol. Chem. 276, 36881–36895.
Hackett, S.F., Wiegand, S., Yancopoulos, G., and Campochiaro, P.A.
(2002). Angiopoietin-2 plays an important role in retinal angiogenesis.
J. Cell. Physiol. 192, 182–187.
Hagen, G., Muller, S., Beato, M., and Suske, G. (1994). Sp1-mediated
transcriptional activation is repressed by Sp3. EMBO J. 13, 3843–3851.
Hammes, H.P., Lin, J., Renner, O., Shani, M., Lundqvist, A., Betsholtz,
C., Brownlee, M., and Deutsch, U. (2002). Pericytes and the pathogene-
sis of diabetic retinopathy. Diabetes 51, 3107–3112.
Hammes, H.P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q.,
Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003). Benfotiamine
blocks three major pathways of hyperglycemic damage and prevents ex-
perimental diabetic retinopathy. Nat. Med. 9, 294–299.
Hammes, H.P., Lin, J., Wagner, P., Feng, Y., Vom Hagen, F., Krzizok, T.,
Renner, O., Breier, G., Brownlee, M., and Deutsch, U. (2004). Angiopoie-
tin-2 causes pericyte dropout in the normal retina: evidence for involve-
ment in diabetic retinopathy. Diabetes 53, 1104–1110.
Hanahan, D. (1997). Signaling vascular morphogenesis and mainte-
nance. Science 277, 48–50.
Hassig, C.A., Fleischer, T.C., Billin, A.N., Schreiber, S.L., and Ayer, D.E.
(1997). Histone deacetylase activity is required for full transcriptional re-
pression by mSin3A. Cell 89, 341–347.
Horsch, M., Hoesch, L., Vasella, A., and Rast, D.M. (1991). N-acetylglu-
cosaminono-1,5-lactone oxime and the corresponding (phenylcarba-
moyl)oxime. Novel and potent inhibitors of beta-N-acetylglucosamini-
dase. Eur. J. Biochem. 197, 815–818.
RE
TR
AIozef, R., Rahlfs, S., Chang, T., Schirmer, H., and Becker, K. (2003).
Glyoxalase I of the malarial parasite Plasmodium falciparum: evidence
for subunit fusion. FEBS Lett. 554, 284–288.
Jain, R.K. (2003). Molecular regulation of vessel maturation. Nat. Med. 9,
685–693.
Kamemura, K., and Hart, G.W. (2003). Dynamic interplay between O-gly-
cosylation and O-phosphorylation of nucleocytoplasmic proteins: a new
paradigm for metabolic control of signal transduction and transcription.
Prog. Nucleic Acid Res. Mol. Biol. 73, 107–136.
Kang, H.T., Ju, J.W., Cho, J.W., and Hwang, E.S. (2003). Down-regula-
tion of Sp1 activity through modulation of O-glycosylation by treatment
with a low glucose mimetic, 2-deoxyglucose. J. Biol. Chem. 278,
51223–51231.
Knoepfler, P.S., and Eisenman, R.N. (1999). Sin meets NuRD and other
tails of repression. Cell 99, 447–450.
Kuzmichev, A., Zhang, Y., Erdjument-Bromage, H., Tempst, P., and Re-
inberg, D. (2002). Role of the Sin3-histone deacetylase complex in growth
regulation by the candidate tumor suppressor p33(ING1). Mol. Cell. Biol.
22, 835–848.
Laherty, C.D., Yang, W.M., Sun, J.M., Davie, J.R., Seto, E., and Eisen-
man, R.N. (1997). Histone deacetylases associated with the mSin3 core-
pressor mediate mad transcriptional repression. Cell 89, 349–356.
Li, L., He, S., Sun, J.M., and Davie, J.R. (2004). Gene regulation by Sp1
and Sp3. Biochem. Cell Biol. 82, 460–471.
Lin, J., Wu, P.H., Tarr, P.T., Lindenberg, K.S., St-Pierre, J., Zhang, C.Y.,
Mootha, V.K., Jager, S., Vianna, C.R., Reznick, R.M., et al. (2004). De-
fects in adaptive energy metabolism with CNS-linked hyperactivity in
PGC-1alpha null mice. Cell 119, 121–135.
Lu, F., Zhou, J., Wiedmer, A., Madden, K., Yuan, Y., and Lieberman, P.M.
(2003). Chromatin remodeling of the Kaposi’s sarcoma-associated her-
pesvirus ORF50 promoter correlates with reactivation from latency. J. Vi-
rol. 77, 11425–11435.
Maeta, K., Izawa, S., Okazaki, S., Kuge, S., and Inoue, Y. (2004). Activity
of the Yap1 transcription factor in Saccharomyces cerevisiae is modu-
lated by methylglyoxal, a metabolite derived from glycolysis. Mol. Cell.
Biol. 24, 8753–8764.
Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J.,
Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopou-
los, N., et al. (1997). Angiopoietin-2, a natural antagonist for Tie2 that dis-
rupts in vivo angiogenesis. Science 277, 55–60.
Metivier, R., Penot, G., Hubner, M.R., Reid, G., Brand, H., Kos, M., and
Gannon, F. (2003). Estrogen receptor-alpha directs ordered, cyclical,
and combinatorial recruitment of cofactors on a natural target promoter.
Cell 115, 751–763.
Phillips, S.A., and Thornalley, P.J. (1993). The formation of methylglyoxal
from triose phosphates. Investigation using a specific assay for methyl-
glyoxal. Eur. J. Biochem. 212, 101–105.
Richard, J.P. (1993). Mechanism for the formation of methylglyoxal from
triosephosphates. Biochem. Soc. Trans. 21, 549–553.
Roos, M.D., Su, K., Baker, J.R., and Kudlow, J.E. (1997). O glycosylation
of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol.
Cell. Biol. 17, 6472–6480.
Sakamoto, H., Mashima, T., Sato, S., Hashimoto, Y., Yamori, T., and
Tsuruo, T. (2001). Selective activation of apoptosis program by S-p-bro-
mobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing
human lung cancer cells. Clin. Cancer Res. 7, 2513–2518.
Sapetschnig, A., Koch, F., Rischitor, G., Mennenga, T., and Suske, G.
(2004). Complexity of translationally controlled transcription factor Sp3
isoform expression. J. Biol. Chem. 279, 42095–42105.
Sarthy, V.P., Brodjian, S.J., Dutt, K., Kennedy, B.N., French, R.P., and
Crabb, J.W. (1998). Establishment and characterization of a retinal Muller
cell line. Invest. Ophthalmol. Vis. Sci. 39, 212–216.
ECell 124, 275–286, January 27, 2006 ª2006 Elsevier Inc. 285
Shinohara, M., Thornalley, P.J., Giardino, I., Beisswenger, P., Thorpe,
S.R., Onorato, J., and Brownlee, M. (1998). Overexpression of glyoxa-
lase-I in bovine endothelial cells inhibits intracellular advanced glycation
endproduct formation and prevents hyperglycemia-induced increases
in macromolecular endocytosis. J. Clin. Invest. 101, 1142–1147.
Skowyra, D., Zeremski, M., Neznanov, N., Li, M., Choi, Y., Uesugi, M.,
Hauser, C.A., Gu, W., Gudkov, A.V., and Qin, J. (2001). Differential asso-
ciation of products of alternative transcripts of the candidate tumor sup-
pressor ING1 with the mSin3/HDAC1 transcriptional corepressor com-
plex. J. Biol. Chem. 276, 8734–8739.
Suske, G. (1999). The Sp-family of transcription factors. Gene 238, 291–
300.
Thornalley, P.J. (2003a). Glyoxalase I—structure, function and a critical
role in the enzymatic defence against glycation. Biochem. Soc. Trans.
31, 1343–1348.
Thornalley, P.J. (2003b). Protecting the genome: defence against nucle-
otide glycation and emerging role of glyoxalase I overexpression in multi-
drug resistance in cancer chemotherapy. Biochem. Soc. Trans. 31,
1372–1377.
Van Herreweghe, F., Mao, J., Chaplen, F.W., Grooten, J., Gevaert, K.,
Vandekerckhove, J., and Vancompernolle, K. (2002). Tumor necrosis fac-
tor-induced modulation of glyoxalase I activities through phosphorylation
by PKA results in cell death and is accompanied by the formation of a spe-
cific methylglyoxal-derived AGE. Proc. Natl. Acad. Sci. USA 99, 949–954.286 Cell 124, 275–286, January 27, 2006 ª2006 Elsevier Inc.
RE
TRVenkatraman, J., Aggarwal, K., and Balaram, P. (2001). Helical peptide
models for protein glycation: proximity effects in catalysis of the Amadori
rearrangement. Chem. Biol. 8, 611–625.
Wells, L., and Hart, G.W. (2003). O-GlcNAc turns twenty: functional impli-
cations for post-translational modification of nuclear and cytosolic pro-
teins with a sugar. FEBS Lett. 546, 154–158.
Yang, X., Su, K., Roos, M.D., Chang, Q., Paterson, A.J., and Kudlow, J.E.
(2001). O-linkage of N-acetylglucosamine to Sp1 activation domain in-
hibits its transcriptional capability. Proc. Natl. Acad. Sci. USA 98, 6611–
6616.
Yang, X., Zhang, F., and Kudlow, J.E. (2002). Recruitment of O-GlcNAc
transferase to promoters by corepressor mSin3A: coupling protein O-
GlcNAcylation to transcriptional repression. Cell 110, 69–80.
Zachara, N.E., and Hart, G.W. (2004). O-GlcNAc modification: a nutri-
tional sensor that modulates proteasome function. Trends Cell Biol. 14,
218–221.
Zhang, Y., and Dufau, M.L. (2002). Silencing of transcription of the human
luteinizing hormone receptor gene by histone deacetylase-mSin3A com-
plex. J. Biol. Chem. 277, 33431–33438.
Zhang, F., Su, K., Yang, X., Bowe, D.B., Paterson, A.J., and Kudlow, J.E.
(2003). O-GlcNAc modification is an endogenous inhibitor of the protea-
some. Cell 115, 715–725. TE
DAC
